Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| HLA-DP Antigens | 4 | 2019 | 38 | 1.88 | Why? |
| HLA-DQ Antigens | 4 | 2018 | 48 | 1.77 | Why? |
| HLA-B Antigens | 4 | 2018 | 166 | 1.62 | Why? |
| HLA-C Antigens | 4 | 2018 | 195 | 1.58 | Why? |
| HLA-A Antigens | 4 | 2018 | 196 | 1.55 | Why? |
| HLA-DR Antigens | 4 | 2018 | 563 | 1.47 | Why? |
| Epitopes, T-Lymphocyte | 9 | 2021 | 2262 | 1.25 | Why? |
| CD4-Positive T-Lymphocytes | 14 | 2021 | 4545 | 1.20 | Why? |
| Dengue Virus | 5 | 2019 | 910 | 1.10 | Why? |
| CD8-Positive T-Lymphocytes | 15 | 2021 | 5837 | 1.05 | Why? |
| Coxsackievirus Infections | 1 | 2019 | 71 | 0.77 | Why? |
| Dengue | 5 | 2019 | 1565 | 0.77 | Why? |
| Enterovirus D, Human | 1 | 2019 | 96 | 0.74 | Why? |
| Immunodominant Epitopes | 3 | 2021 | 813 | 0.74 | Why? |
| Myelitis | 1 | 2019 | 122 | 0.70 | Why? |
| Central Nervous System Viral Diseases | 1 | 2019 | 117 | 0.69 | Why? |
| T-Lymphocytes | 5 | 2019 | 6670 | 0.66 | Why? |
| Enterovirus A, Human | 1 | 2019 | 180 | 0.66 | Why? |
| Neuromuscular Diseases | 1 | 2019 | 303 | 0.59 | Why? |
| Antigens, Viral | 7 | 2021 | 6298 | 0.50 | Why? |
| Adaptive Immunity | 2 | 2021 | 2585 | 0.47 | Why? |
| Zika Virus | 2 | 2018 | 1924 | 0.37 | Why? |
| B-Lymphocytes | 3 | 2021 | 4418 | 0.37 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.37 | Why? |
| Computational Biology | 3 | 2020 | 4514 | 0.36 | Why? |
| Interferon-gamma | 6 | 2021 | 2711 | 0.34 | Why? |
| Immunologic Memory | 6 | 2021 | 3362 | 0.34 | Why? |
| Cross Reactions | 5 | 2021 | 4374 | 0.32 | Why? |
| Gene Frequency | 4 | 2018 | 1210 | 0.31 | Why? |
| Zika Virus Infection | 2 | 2018 | 1920 | 0.30 | Why? |
| Tuberculosis | 2 | 2021 | 2895 | 0.30 | Why? |
| Epitope Mapping | 3 | 2020 | 1240 | 0.29 | Why? |
| Databases, Protein | 2 | 2020 | 523 | 0.29 | Why? |
| Histocompatibility Testing | 3 | 2018 | 219 | 0.25 | Why? |
| T-Lymphocyte Subsets | 2 | 2021 | 1387 | 0.24 | Why? |
| Epitopes | 3 | 2021 | 4113 | 0.24 | Why? |
| Sequence Analysis, DNA | 4 | 2018 | 2830 | 0.23 | Why? |
| Sequence Homology | 2 | 2020 | 448 | 0.23 | Why? |
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 78 | 0.22 | Why? |
| Receptors, Antigen | 1 | 2019 | 5 | 0.21 | Why? |
| Immunity, Cellular | 4 | 2021 | 3614 | 0.20 | Why? |
| Receptors, Tumor Necrosis Factor | 1 | 2018 | 40 | 0.19 | Why? |
| Genotype | 4 | 2018 | 4697 | 0.19 | Why? |
| Alleles | 3 | 2019 | 1557 | 0.18 | Why? |
| Granzymes | 1 | 2018 | 197 | 0.18 | Why? |
| Th1 Cells | 2 | 2021 | 1228 | 0.18 | Why? |
| Common Variable Immunodeficiency | 1 | 2020 | 195 | 0.18 | Why? |
| HLA-DRB1 Chains | 1 | 2019 | 196 | 0.17 | Why? |
| Endosomes | 1 | 2021 | 490 | 0.17 | Why? |
| Immunophenotyping | 2 | 2021 | 1290 | 0.17 | Why? |
| Sri Lanka | 1 | 2017 | 241 | 0.17 | Why? |
| Cytotoxicity, Immunologic | 1 | 2018 | 287 | 0.16 | Why? |
| Transcriptome | 2 | 2020 | 3466 | 0.16 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 552 | 0.16 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2017 | 325 | 0.15 | Why? |
| Healthy Volunteers | 2 | 2021 | 1444 | 0.15 | Why? |
| 3' Untranslated Regions | 1 | 2017 | 318 | 0.15 | Why? |
| Species Specificity | 1 | 2019 | 1356 | 0.14 | Why? |
| Lymphocyte Activation | 3 | 2021 | 2742 | 0.14 | Why? |
| Databases, Genetic | 2 | 2018 | 1127 | 0.14 | Why? |
| Antibody Specificity | 1 | 2019 | 1328 | 0.14 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2020 | 698 | 0.13 | Why? |
| Carrier Proteins | 1 | 2017 | 513 | 0.13 | Why? |
| Cells, Cultured | 3 | 2021 | 5835 | 0.13 | Why? |
| Peptides | 3 | 2021 | 2513 | 0.13 | Why? |
| Receptors, Antigen, T-Cell | 1 | 2019 | 760 | 0.13 | Why? |
| Immunoglobulins | 1 | 2018 | 811 | 0.12 | Why? |
| B7-H1 Antigen | 1 | 2016 | 541 | 0.12 | Why? |
| Sequence Deletion | 1 | 2017 | 674 | 0.12 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2020 | 1267 | 0.12 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2019 | 2483 | 0.11 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2016 | 724 | 0.11 | Why? |
| HLA Antigens | 1 | 2017 | 830 | 0.11 | Why? |
| Proteins | 1 | 2018 | 921 | 0.11 | Why? |
| Leukocytes, Mononuclear | 1 | 2020 | 2115 | 0.10 | Why? |
| Spike Glycoprotein, Coronavirus | 10 | 2021 | 37182 | 0.10 | Why? |
| Sequence Analysis, RNA | 1 | 2019 | 2290 | 0.10 | Why? |
| Software | 2 | 2018 | 2501 | 0.10 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.10 | Why? |
| Humans | 30 | 2021 | 930598 | 0.10 | Why? |
| Phenotype | 1 | 2020 | 4037 | 0.09 | Why? |
| Convalescence | 1 | 2020 | 2829 | 0.09 | Why? |
| Antibodies, Viral | 8 | 2021 | 51949 | 0.09 | Why? |
| South Africa | 1 | 2018 | 3326 | 0.09 | Why? |
| Linkage Disequilibrium | 2 | 2018 | 191 | 0.09 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.08 | Why? |
| Multiple Myeloma | 1 | 2016 | 1064 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.08 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.08 | Why? |
| Signal Transduction | 1 | 2021 | 7207 | 0.07 | Why? |
| Adult | 16 | 2021 | 244371 | 0.07 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.07 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.06 | Why? |
| Large Neutral Amino Acid-Transporter 1 | 1 | 2021 | 13 | 0.06 | Why? |
| Forkhead Box Protein O1 | 1 | 2021 | 31 | 0.06 | Why? |
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 54 | 0.06 | Why? |
| Mice | 2 | 2021 | 21357 | 0.06 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.06 | Why? |
| Antigens, Differentiation, T-Lymphocyte | 1 | 2021 | 146 | 0.05 | Why? |
| Vesicular Transport Proteins | 1 | 2021 | 110 | 0.05 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.05 | Why? |
| Autophagy-Related Proteins | 1 | 2021 | 157 | 0.05 | Why? |
| Adoptive Transfer | 1 | 2021 | 250 | 0.05 | Why? |
| Immunoglobulin M | 1 | 2017 | 9091 | 0.05 | Why? |
| Receptors, CCR7 | 1 | 2019 | 40 | 0.05 | Why? |
| Male | 14 | 2021 | 367725 | 0.05 | Why? |
| Female | 14 | 2021 | 380317 | 0.05 | Why? |
| Leukocyte Common Antigens | 1 | 2019 | 101 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2019 | 11041 | 0.05 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.05 | Why? |
| Lectins, C-Type | 1 | 2021 | 405 | 0.05 | Why? |
| Nicaragua | 1 | 2017 | 71 | 0.04 | Why? |
| Transfection | 1 | 2021 | 864 | 0.04 | Why? |
| Cytokines | 4 | 2021 | 15010 | 0.04 | Why? |
| Lysosomes | 1 | 2021 | 416 | 0.04 | Why? |
| Antigens, Bacterial | 1 | 2021 | 330 | 0.04 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.04 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.04 | Why? |
| Bone Marrow Examination | 1 | 2016 | 24 | 0.04 | Why? |
| Genetics, Population | 1 | 2017 | 162 | 0.04 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.04 | Why? |
| Leukemic Infiltration | 1 | 2016 | 9 | 0.04 | Why? |
| Th2 Cells | 1 | 2020 | 680 | 0.04 | Why? |
| Amino Acid Sequence | 2 | 2018 | 6049 | 0.04 | Why? |
| Antigens, CD | 1 | 2021 | 984 | 0.04 | Why? |
| Genotyping Techniques | 1 | 2018 | 360 | 0.04 | Why? |
| Erythropoietin | 1 | 2017 | 167 | 0.04 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.04 | Why? |
| CD4 Lymphocyte Count | 1 | 2020 | 1517 | 0.04 | Why? |
| Florida | 1 | 2017 | 598 | 0.04 | Why? |
| Purines | 1 | 2021 | 816 | 0.04 | Why? |
| Aged | 9 | 2021 | 215776 | 0.04 | Why? |
| Longitudinal Studies | 2 | 2021 | 9893 | 0.04 | Why? |
| Azetidines | 1 | 2021 | 722 | 0.04 | Why? |
| Mice, Transgenic | 1 | 2021 | 2739 | 0.03 | Why? |
| Antibodies, Neutralizing | 4 | 2021 | 25288 | 0.03 | Why? |
| Ligands | 1 | 2018 | 1300 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.03 | Why? |
| Immunization, Secondary | 1 | 2021 | 1649 | 0.03 | Why? |
| Open Reading Frames | 1 | 2020 | 1898 | 0.03 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.03 | Why? |
| Animals | 2 | 2021 | 78931 | 0.03 | Why? |
| Sulfonamides | 1 | 2021 | 1294 | 0.03 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.03 | Why? |
| California | 1 | 2018 | 2047 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| User-Computer Interface | 1 | 2017 | 1068 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2017 | 1706 | 0.03 | Why? |
| Mice, Inbred C57BL | 1 | 2021 | 5542 | 0.03 | Why? |
| Pyrazoles | 1 | 2021 | 1791 | 0.03 | Why? |
| Single-Cell Analysis | 1 | 2020 | 2450 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2016 | 2275 | 0.02 | Why? |
| England | 1 | 2020 | 5116 | 0.02 | Why? |
| Exanthema | 1 | 2017 | 1097 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2021 | 3129 | 0.02 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.02 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.02 | Why? |
| Blood Donors | 1 | 2020 | 2956 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Gene Expression | 1 | 2016 | 3332 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2017 | 3539 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Protein Binding | 1 | 2017 | 11430 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.01 | Why? |
| Adolescent | 2 | 2019 | 86841 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| United States | 1 | 2021 | 46150 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2017 | 27595 | 0.01 | Why? |
Grifoni's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(178)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(181)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_